News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Conversant Bio Publishes Guide To Multiple Myeloma



5/21/2014 9:57:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HUNTSVILLE, AL--(Marketwired - May 20, 2014) -

Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples, today announced it is publishing a guide about multiple myeloma. The e-book, Researcher's Guide to Multiple Myeloma: From the Real World to the Lab, is available as a free download at: http://www.conversantbio.com/multiple-myeloma-ebook

Multiple myeloma is a hematologic cancer that develops in the marrow of the long bones. Researchers are working toward a cure, and this new e-book provides them with a basic foundation of how the disease is approached in the real world. Features of the guide include:

  • How multiple myeloma is diagnosed
  • The different types of multiple myeloma
  • Labwork results of typical multiple myeloma patients in different stages
  • Treatments and side effects

Furthermore, the e-book also details the challenges faced when studying multiple myeloma, including obtaining quality bone marrow and blood samples that are integral for research.

"Researchers will benefit from this e-book when they are developing the criteria and parameters of their multiple myeloma research," says Luke Doiron, Chief Commercial Officer of Conversant Bio. "They will gain a new perspective on the disease that is outside the scope of the lab. And if they are in need of high-quality bone marrow and blood samples for their research, they can achieve access to such samples through Conversant Bio"

To download Researcher's Guide to Multiple Myeloma: From the Real World to the Lab, visit http://www.conversantbio.com/multiple-myeloma-ebook.

About Conversant Bio
Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting-edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S.-based clinical sites and an IRB-reviewed chain of custody quality control system, Conversant Bio provides the highest-quality samples on time and on budget. For additional information about Conversant Bio's services, visit the company's website at http://www.conversantbio.com.




Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES